BioCardia says FDA confirms Helix catheter meeting minutes
BioCardia says the FDA confirmed meeting minutes supporting a follow-on de novo pre-submission for approval of its Helix transendocardial delivery catheter, and it plans to submit the pre-submission this quarter.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.